Close 2026-08-21 1267 scanned A

FERMENTA

Fermenta Biotech
Small capRs 1,372 crRs 6.9 cr traded a day
Close on 2026-08-21
478.35
+3.97%
52-week range72% of the way up
262.85560.60
Market cap
1,372 cr
P/E (TTM)
23.6×
EPS (TTM)
20.29
Revenue YoY
-10.6%
Q1 FY27
Profit YoY
-55.9%
Net margin
7.8%
-8.0pt vs a year ago
Growth trend
+2.5pt
vs last quarter’s YoY
1 month
+19.3%
Below 52w high
17.2%
RSI (14)
41
Daily swing
6.4%
average true range
Volume
0.4×
vs 20-day average
Traded
Rs 7 cr
median day
Close200-day averageMaterial filing
300400500Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26
260 sessions · hover for the filing behind a move
1 week
+6.29%
1 month
+19.29%
3 months
+66.30%
6 months
+49.60%
1 year
+35.45%

The read

written from the numbers on this page
The evidence leans constructive5 supporting, 2 against, 0 worth knowing

Supporting

  • trading 39% above its 200-day average
  • up 35% over twelve months
  • matches gapped up and held it, which has beaten the market by +2.66 points over 20 sessions across 11,111 past signals
  • 2 of the scans it matches have a positive measured record
  • 5 independent kinds of evidence agree today, which is uncommon

Against

  • revenue fell 11% year on year in the quarter ending 2026-06-30
  • net margin has narrowed from 13.8% to 7.8% across four quarters

Worth knowing

  • nothing the data supports either way
What would change this read: a close below 344, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.

What is working, what is not

read from the filings, with the figure behind every line
Working
Nothing in the filings stands out either way.
Needs watching3

Net profit -55.9% year on year, Rs 22 cr to Rs 10 cr.

-55.9%Rs 22 crRs 10 cr

Net margin moved from 15.9% to 7.8%.

15.9%7.8%

Profit grew slower than revenue, -55.9% against -10.6%.

-55.9%-10.6%
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.

How it has performed

price return over each window, measured against zero
+6.3%1W+19.3%1M+66.3%3M+49.6%6M+35.5%1Y

What the scans say today

6 of 47 matched on 2026-08-21
FERMENTA matches 6 of the 47 scans today, across 5 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.

Valuation against its own history

135 sessions since 2026-02-09
10×
median 12×
23×
now 24×
FERMENTA trades at 24× trailing earnings, above its median of 12× over this window — 104% more expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.

Recent filings

from the exchange, newest first
08-17
16:40
Credit rating
1d-0.55d20d
08-11
23:04
AGM / EGM
1d-1.75d-5.220d
08-11
23:00
AGM / EGM
1d-1.75d-5.220d
Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352) · Credit rating filings were typically +0.58pt vs the market over the next 5 sessions (n=266) · Results filings were typically -0.52pt vs the market over the next 5 sessions (n=7,520)

The business

from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
14013613013712212223.8%15.9%13.8%8.8%15.3%7.8%Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.

Going for it

  • nothing clear in the filed numbers

Going against it

  • revenue fell 11% against the same quarter a year earlier
  • profit dropped 56% year on year
  • net margin narrowed from 15.3% to 7.8%
Quarter-by-quarter numbers, as filed
QuarterRevenueProfit before taxNet profitEPSNet margin
Q1 FY27
2026-06-30 · consolidated
12215103.407.8%
Q4 FY26
2026-03-31 · consolidated
12226196.6615.3%
Q3 FY26
2025-12-31 · consolidated
13717124.368.8%
Q2 FY26
2025-09-30 · consolidated
13024186.4813.8%
Q1 FY26
2025-06-30 · consolidated
13628227.4915.9%
Q4 FY25
2025-03-31 · consolidated
140323311.7923.8%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.

Where the price stands

the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+12.5%
Versus 200-day average+39.0%
Below 52-week high-14.7%
Above 52-week low+82.0%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)41.4
Higher closes in last 54 of 5
Six-month return+49.60%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)6.43%
Volume versus 20-day0.4x
Median daily turnoverRs 6.9 cr